Androgen deprivation therapy improves the in vitro capacity of high-density lipoprotein (HDL) to receive cholesterol and other lipids in patients with prostate carcinoma

BACKGROUND: Androgen deprivation therapy (ADT) is widely used in the treatment of testosterone-dependent prostate carcinomas. ADT often increases plasma LDL and HDL cholesterol and triglycerides. The aim was to test whether ADT changes the transfer of lipids to HDL, an important aspect of this metab...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Lipids Health Dis
Main Authors: Albuquerque, Cicero P., Freitas, Fatima R., Martinelli, Ana Elisa M., Lima, Josefa H., Coelho, Rafael F., Serrano Jr., Carlos V., Nahas, Willian C., Kalil Filho, Roberto, Maranhão, Raul C.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2020
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7285573/
https://ncbi.nlm.nih.gov/pubmed/32522195
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12944-020-01305-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados